Investors

Corporate News

2015

10 December TR-1 Notification of Major Interest in Shares
30 November Lamda out-licensing agreements
26 November TR-1 Notification of Major Interest in Shares
25 November TR-1 Notification of Major Interest in Shares
16 November TR-1 Notification of Major Interest in Shares
05 November Mucodis® Medical Device Launch
23 October TR-1 Notification of Major Interest in Shares
20 October Nicola Massey announced as Managing Director of Niche Pharmaceuticals
20 October Half year results for the six months to 31 July 2015
15 October Quantum Pharma announces Lamda out-licensing agreements
14 October Exclusive Licensing Agreement with Futura Medical plc
12 October Quantum Pharma announces out-licensing agreement
07 October Notice of Half Year Results
28 September TR-1 Notification of Major Interest in Shares
21 September Quantum Pharma announces major Biodose® Services contract
21 August TR-1 Notification of Major Interest in Shares
20 August Pre-close Trading Statement and Notice of Half Year Results
21 July Result of AGM
15 July Launch of 2015 SAYE Scheme
14 July Acquisition of NuPharm Group for initial consideration of £9.34 million and
Arrangement of New Banking Facilities totalling £35 million
25 June Annual Report and Accounts
Notice of Annual General Meeting
03 June TR-1 Notification of Major Interest in Shares
03 June TR-1 Notification of Major Interest in Shares
03 June TR-1 Notification of Major Interest in Shares
01 June Sale of Ordinary Shares in Quantum
27 May TR-1 Notification of Major Interest in Shares
20 May Final Results
08 May Notice of Final Results
20 April TR-1 Notification of Major Interest in Shares
17 April Acquisition of Lamda companies for 9.7 million
27 March TR-1 Notification of Major Interest in Shares
09 March TR-1 Notification of Major Interest in Shares
09 February Pre-close Trading Update

 

Quantum Pharmaceuticals
UL Medicines
Quantum Aseptics
PERN Consumer Products
Biodose Intelligent Medication Management
Biodose Services